UGI CFO exercises 23,773 options and sells 28,709 shares

UGI Corporation's Chief Financial Officer Sean O'Brien reported an option exercise and related stock sales.

Rhea-AI Filing Summary

UGI Corporation's Chief Financial Officer Sean O'Brien reported an option exercise and related stock sales. On 12/05/2025, he exercised 23,773 options to buy UGI common stock at an exercise price of $24.6 per share, increasing his directly held common shares to 28,709.

On the same date, he sold 23,773 shares of UGI common stock at an average price of $37.647 per share and an additional 4,936 shares at the same average price, leaving him with 0 directly held common shares after these transactions. Following the option exercise, he continued to hold 47,547 derivative securities (stock options) directly. The company notes that the sale prices ranged from $37.54 to $37.6894, with detailed trade breakdowns available upon request.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider O'Brien Sean

Role Chief Financial Officer

Sold 28,709 shs ($1.08M)

Approx. gross sale proceeds $1.08M

Approx. exercise cost $585K

Type	Security	Shares	Price	Value
Exercise	Options (Right to Buy)	23,773	$0.00	$0.00
Exercise	UGI Common Stock	23,773	$24.60	$585K
Sale	UGI Common Stock	23,773	$37.647	$895K
Sale	UGI Common Stock	4,936	$37.647	$186K

Holdings After Transaction: Options (Right to Buy) — 47,547 contracts (Direct); UGI Common Stock — 0 shares (Direct)

Footnotes (1)

1. F1. The shares of common stock with respect to this transaction were sold at prices ranging from $37.54 to $37.6894. Upon request, UGI Corporation will provide to the U.S. Securities and Exchange Commission staff, or a security holder of UGI Corporation, full information regarding the number of shares of common stock sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UGI (UGI) disclose for its CFO?

UGI disclosed that Chief Financial Officer Sean O'Brien exercised 23,773 stock options at an exercise price of $24.6 per share on 12/05/2025 and sold the underlying common shares the same day.

How many UGI shares did the CFO sell in this transaction?

On 12/05/2025, the CFO sold 23,773 shares of UGI common stock at an average price of $37.647 per share and a further 4,936 shares at the same average price, for a total of 28,709 shares sold.

What were the price ranges for the UGI stock sales reported by the CFO?

The filing states that the UGI common shares were sold at prices ranging from $37.54 to $37.6894 per share, with a reported average sale price of $37.647 for the disclosed transactions.

How many UGI common shares did the CFO hold after these transactions?

After the reported sales on 12/05/2025, the CFO's directly held UGI common stock position shown in the filing was 0 shares.

What derivative securities related to UGI stock does the CFO still hold?

Following the option exercise transaction, the filing shows that the CFO directly held 47,547 derivative securities, consisting of stock options relating to UGI common stock.

What role does the reporting person hold at UGI (UGI)?

The reporting person, Sean O'Brien, is identified as an Officer of UGI Corporation with the title Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/09/2025 - 04:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Brien Sean

(Last) (First) (Middle)

500 NORTH GULPH ROAD

(Street)

KING OF PRUSSIA PA 19406

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UGI CORP /PA/ [ UGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
UGI Common Stock	12/05/2025		M		23,773	A	$24.6	28,709	D
UGI Common Stock	12/05/2025		S		23,773	D	$37.647(1)	4,936	D
UGI Common Stock	12/05/2025		S		4,936	D	$37.647(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$24.6	12/05/2025		M			23,773	01/01/2025	12/31/2033	UGI Common Stock	23,773	$0	47,547	D

Explanation of Responses:

1. The shares of common stock with respect to this transaction were sold at prices ranging from $37.54 to $37.6894. Upon request, UGI Corporation will provide to the U.S. Securities and Exchange Commission staff, or a security holder of UGI Corporation, full information regarding the number of shares of common stock sold at each separate price.

	/s/ Pamela A. Meredith, Attorney-in-Fact for Sean O'Brien	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.